Home - Products - Others - Other Targets - Brain Injury Derived Neurotrophic Peptide

Brain Injury Derived Neurotrophic Peptide

CAS No. 148330-12-5

Brain Injury Derived Neurotrophic Peptide( ——— )

Catalog No. M42153 CAS No. 148330-12-5

Brain Injury Derived Neurotrophic Peptide

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Brain Injury Derived Neurotrophic Peptide
  • Note
    Research use only, not for human use.
  • Brief Description
    Brain Injury Derived Neurotrophic Peptide
  • Description
    Brain Injury Derived Neurotrophic Peptide
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    148330-12-5
  • Formula Weight
    1387.61
  • Molecular Formula
    C62H102N18O18
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Procodazole

    Procodazole is a non-specific active immunoprotective agent against viral and bacterial infections, used as a potentiator.

  • Gomisin L1

    Gomisin L1 is a lignan, shows inhibitory effect on cell viability of A2780 and Ishikawa cells, with IC50s of 39.06 μM and 74.16 μM, respectively.

  • Decyl-TPP bromide

    Decyl-TPP bromide may be used as an intermediate for chemical synthesis and an inactive control or as a reference to mitoquinone (MitoQ).